ALK and hepatocellular carcinoma: In addition to HCC, ALK overexpression or phosphorylation is linked to unfavorable course of disease also in inflammatory breast cancer [17] as well as neuroblastoma, where ALK phosphorylation is linked to activating mutations of the ALK gene [18].